UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
AUGUST 20, 1998
---------------
(Date of earliest event reported)
LABORATORY CORPORATION OF AMERICA HOLDINGS
------------------------------------------
(Exact name of registrant as specified in its charter)
DELAWARE 1-11353 13-3757370
-------- ------- ----------
(State or other (Commission (IRS Employer
jurisdiction of File Number) Identification
incorporation) Number)
358 SOUTH MAIN STREET, BURLINGTON, NORTH CAROLINA 27215
-------------------------------------------------------
(Address of principal executive offices)
336-229-1127
------------
(Registrant's telephone number, including area code)
<PAGE>
<PAGE>
ITEM 5. OTHER EVENTS
On August 20, 1998, the Company issued a press release announcing that its
Board of Directors has declared dividends on the Company's 8 1/2% Series A
Convertible Exchangeable Preferred Stock and the Company's 8 1/2% Series B
Convertible Pay-in-Kind Preferred Stock.
ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL
INFORMATION AND EXHIBITS
(c) Exhibit
20 Press release of the Company dated
August 20,1998.
<PAGE>
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities and Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
LABORATORY CORPORATION OF AMERICA HOLDINGS
------------------------------------------
(Registrant)
By:/s/ BRADFORD T. SMITH
------------------------------
Bradford T. Smith
Executive Vice President,
General Counsel, Secretary
and Compliance Officer
Date: August 26, 1998
<PAGE>
<PAGE>
2
Laboratory Corporation of America-Registered Trademark- Holdings
358 South Main Street
Burlington, NC 27215
FOR IMMEDIATE RELEASE
_____________________
CONTACT: PAMELA SHERRY
336-584-5171, EXT. 4855
SHAREHOLDER DIRECT: 800-LAB-0401
WWW.LABCORP.COM
LABORATORY CORPORATION OF AMERICA-REGISTERED TRADEMARK- DECLARES PREFERRED
STOCK DIVIDENDS
BURLINGTON, NC, AUGUST 20, 1998 - Laboratory Corporation of America-Registered
Trademark- Holdings (LabCorp-Registered Trademark-) (NYSE: LH) today announced
that its Board of Directors has declared a dividend of $1.0625 per share on the
Company's 8 1/2 % Series A Convertible Exchangeable Preferred Stock (Series A
Preferred Stock), payable in cash. The Board has also declared a dividend of
$1.0625 per share on the Company's 8 1/2 % Series B Convertible Pay-in-Kind
Preferred Stock (Series B Preferred Stock), payable in shares of Series B
Preferred Stock at the rate of 0.02125 shares per share of Series B Preferred
Stock held. No fractional shares of Series B Preferred Stock will be issued,
so that the number of shares to be paid as a dividend on the Series B Preferred
Stock will be rounded to the nearest whole number of shares. The dividends
will be payable on September 30, 1998 for each issued and outstanding share
of Series A and B Preferred Stock to stockholders of record on
September 21, 1998, and will cover the dividend period from July 1, 1998 to
September 30, 1998 at an equivalent annualized rate of $4.25 per share.
Laboratory Corporation of America-Registered Trademark- Holdings (LabCorp-
Registered Trademark-) is a national clinical laboratory organization with
annual revenues of $1.5 billion in 1997. The Company operates primary testing
facilities nationally, offering more than 1,700 different clinical assays, from
routine blood analyses to more sophisticated technologies. LabCorp performs
diagnostic tests for physicians, managed-care organizations, hospitals,
clinics, long-term care facilities, industrial companies and other clinical
laboratories.
###
